Table of Contents Author Guidelines Submit a Manuscript
Anemia
Volume 2015, Article ID 189404, 9 pages
http://dx.doi.org/10.1155/2015/189404
Research Article

The Cost-Effectiveness of Continuous Erythropoiesis Receptor Activator Once Monthly versus Epoetin Thrice Weekly for Anaemia Management in Chronic Haemodialysis Patients

1Research Team of Pharmacoepidemiology & Pharmacoeconomics, Medical and Pharmacy School, Mohammed V University, Madinat Al Irfane, 10000 Rabat, Morocco
2Department of Nephrology & Dialysis, Military Hospital Agadir, 20450 Agadir, Morocco
3Meknes Dialysis Center (on Behalf of Moroccan Society of Nephrology), 33150 Meknes, Morocco
4IdrissAlakbar Dialysis Center (on Behalf of the Scientific Committee, Moroccan Society of Nephrology), 12470 Rabat, Morocco

Received 2 October 2015; Accepted 6 December 2015

Academic Editor: Eitan Fibach

Copyright © 2015 Omar Maoujoud et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

Omar Maoujoud, Samir Ahid, Hocein Dkhissi, Zouhair Oualim, and Yahia Cherrah, “The Cost-Effectiveness of Continuous Erythropoiesis Receptor Activator Once Monthly versus Epoetin Thrice Weekly for Anaemia Management in Chronic Haemodialysis Patients,” Anemia, vol. 2015, Article ID 189404, 9 pages, 2015. https://doi.org/10.1155/2015/189404.